Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis
1 other identifier
observational
10,690
1 country
1
Brief Summary
The tongue images of patients with gastrointestinal diseases and healthy people will be collected and the tongue image database will be established. Through deep learning and artificial intelligence, early screening models of various gastrointestinal tumors based on tongue images were constructed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2020
CompletedFirst Submitted
Initial submission to the registry
December 21, 2021
CompletedFirst Posted
Study publicly available on registry
January 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2022
CompletedJune 16, 2022
June 1, 2022
1.3 years
December 21, 2021
June 14, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnosis
The differences of tongue images between patients with digestive tract diseases and healthy people
1 year
Study Arms (2)
People with digestive tract diseases
Healthy people
Interventions
Take photos of the tongue of patients with gastrointestinal diseases and collect clinical information.
Eligibility Criteria
Hospitalized patients with gastrointestinal diseases and healthy people
You may qualify if:
- Be older than 18 years old;
- Clinical or pathological diagnosis of Digestive tract diseases;
- Patients before receiving surgery, chemotherapy, radiotherapy, targeted therapy, local therapy, immunotherapy and other treatment measures;
- The patient had no tongue disease
- Patients understand and are willing to sign written informed consent.
You may not qualify if:
- Patients unable to complete the process as required (mental disorder or poor compliance, etc.);
- The patient or guardian is unwilling to participate in this study;
- Combined with other serious systemic diseases (heart failure, renal failure,hematopoietic system disease or Uncontrollable acute infection);
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gang Chen
Wenzhou, Zhejiang, 325000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gang Chen, M.D.
First Affiliated Hospital of Wenzhou Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor, Principal Investigator
Study Record Dates
First Submitted
December 21, 2021
First Posted
January 10, 2022
Study Start
November 15, 2020
Primary Completion
February 20, 2022
Study Completion
April 25, 2022
Last Updated
June 16, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share